Are Lactated Ringer’s Solution and Normal Saline Solution Equal with Regard to Coagulation?: Retracted
- 1 February 2002
- journal article
- retracted article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 94 (2) , 378-384
- https://doi.org/10.1097/00000539-200202000-00028
Abstract
Crystalloids represent an attractive strategy to alleviate intravascular volume deficits. Crystalloid hemodilution was associated with hypercoagulability in in vitro and in vivo studies. The influence of different crystalloids on coagulation in the surgical patient is not well studied. In a prospective, randomized study in patients undergoing major abdominal surgery, we used either lactated Ringer's solution (RL) (n = 21) or 0.9% saline solution (SS) (n = 21) exclusively for intravascular volume replacement over 48 h to maintain central venous pressure between 8 and 12 mm Hg. Activated throm-belastography (TEG(R)) using different activators (intrinsic TEG, extrinsic TEG, heparinase TEG, aprotinin TEG) was used to measure coagulation time, clot formation time, and maximum clot firmness. Measurements were performed after induction of anesthesia (T0), immediately after surgery (T1), 5 h after surgery (T2), and on the morning of the first (T3) and second (T4) postoperative days. RL 18750 +/- 1890 mL and 17990 +/- 1790 mL of SS were infused during the study period. Acidosis was seen only in the SS-treated group. Blood loss was not different between the groups. Fibrinogen and antithrombin III decreased similarly at T1 and T2 in both groups, most likely because of hemodilution. Differences in TEG(R) data from normal baseline were seen only immediately after surgery and 5 h thereafter, indicating mild hypercoagulability in the intrinsic TEG(R) (RL, from 147 +/- 130s to 130 +/- 11s; SS, from 146 +/- 12s to 131 +/- 12s). There were no differences in coagulation between RL- and SS-treated patients. We conclude that in major abdominal surgery intravascular volume replacement with crystalloids resulted in only moderate and abbreviated changes in coagulation, No differences in activated TEG(R) and blood loss were seen between an RL- and an SS-based intravascular volume replacement regimen.This publication has 22 references indexed in Scilit:
- Thromboelastography for Monitoring Prolonged Hypercoagulability After Major Abdominal SurgeryAnesthesia & Analgesia, 2001
- The Effect of In Vitro Hemodilution with Gelatin, Dextran, Hydroxyethyl Starch, or Ringer’s Solution on Thrombelastograph®Anesthesia & Analgesia, 2000
- Assessing Platelet and Fibrinogen Contribution to Clot Strength Using Modified Thromboelastography in Pregnant WomenAnesthesia & Analgesia, 1999
- Thromboelastography-Guided Transfusion Algorithm Reduces Transfusions in Complex Cardiac SurgeryAnesthesia & Analgesia, 1999
- Pigs are not humansBritish Journal of Anaesthesia, 1997
- Dilutional AcidosisAnesthesiology, 1997
- Haemodilution induces a hypercoagulable stateBritish Journal of Anaesthesia, 1996
- Evaluation of a New Hydroxyethyl Starch, Preparation (Hextend™) on Selected Coagulation ParametersClinical and Applied Thrombosis/hemostasis, 1995
- Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assayJournal of Cardiothoracic and Vascular Anesthesia, 1994
- Postoperative deep vein thrombosis caused by intravenous fluids during surgeryBritish Journal of Surgery, 1980